Press enter to begin your search

ValiRx - Update on proposed sub-license of VAL201

VAL
Wed, 23 Mar 2022, 12:56 GMT

Dr Suzy Dilly, CEO of ValiRx provides an update on the progress made towards the completion of the proposed sub-license of VAL201 to TheoremRx Inc.

Dr Suzanne Dilly
Chief Executive Officer
VAL
623af89c59290338057148f9
SHOW MORE
FROM THIS COMPANY
ValiRx - Update on proposed sub-license of VAL201
VAL Wed, 23 Mar 2022, 12:56 GMT

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Industry: Health Care

Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/

Dr Suzy Dilly, CEO of ValiRx provides an update on the progress made towards the completion of the proposed sub-license of VAL201 to TheoremRx Inc.

Dr Suzanne Dilly
Chief Executive Officer
POWERED BY